From July 21, 2023 to August 17, 2023, the company has repurchased 665,000 shares, representing 0.72% for INR 598.5 million. With this, the company has completed the repurchase of 665,000 shares, representing 0.72% for INR 598.5 million under the buyback announced on July 21, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
474.4 INR | -0.35% | -5.99% | -3.01% |
May. 06 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 | |
May. 03 | Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.01% | 524M | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- News Aarti Drugs Limited
- Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.